These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 9186374

  • 1. Somatic mutation of the tuberous sclerosis (Tsc2) tumor suppressor gene in chemically induced rat renal carcinoma cell.
    Urakami S, Tokuzen R, Tsuda H, Igawa M, Hino O.
    J Urol; 1997 Jul; 158(1):275-8. PubMed ID: 9186374
    [Abstract] [Full Text] [Related]

  • 2. Biallelic mutations of the Tsc2 gene in chemically induced rat renal cell carcinoma.
    Satake N, Urakami S, Hirayama Y, Izumi K, Hino O.
    Int J Cancer; 1998 Sep 11; 77(6):895-900. PubMed ID: 9714060
    [Abstract] [Full Text] [Related]

  • 3. Development of high-grade renal cell carcinomas in rats independently of somatic mutations in the Tsc2 and VHL tumor suppressor genes.
    Toyokuni S, Okada K, Kondo S, Nishioka H, Tanaka T, Nishiyama Y, Hino O, Hiai H.
    Jpn J Cancer Res; 1998 Aug 11; 89(8):814-20. PubMed ID: 9765616
    [Abstract] [Full Text] [Related]

  • 4. Renal cell carcinoma development in the rat independent of alterations at the VHL gene locus.
    Walker C, Ahn YT, Everitt J, Yuan X.
    Mol Carcinog; 1996 Feb 11; 15(2):154-61. PubMed ID: 8599582
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. N-ethyl-N-hydroxyethylnitrosamine (EHEN)-induced renal and hepatocarcinogenesis in the tumor suppressor Tsc2 transgenic rat.
    Satake N, Miyagawa M, Sakurai J, Mitani H, Kobayashi T, Tamura H, Hino O.
    Cancer Lett; 2002 Oct 28; 184(2):157-63. PubMed ID: 12127687
    [Abstract] [Full Text] [Related]

  • 7. [Frequent somatic mutations of the von Hippel-Lindau tumor suppressor gene in primary sporadic human renal clear cell carcinomas].
    Gong K, Zhang Z, Xin D.
    Zhonghua Yi Xue Za Zhi; 2001 Feb 10; 81(3):142-4. PubMed ID: 11798864
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mutational analysis of the von hippel lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients.
    Duffy K, Al-Saleem T, Karbowniczek M, Ewalt D, Prowse AH, Henske EP.
    Mod Pathol; 2002 Mar 10; 15(3):205-10. PubMed ID: 11904337
    [Abstract] [Full Text] [Related]

  • 10. VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.
    Brauch H, Weirich G, Brieger J, Glavac D, Rödl H, Eichinger M, Feurer M, Weidt E, Puranakanitstha C, Neuhaus C, Pomer S, Brenner W, Schirmacher P, Störkel S, Rotter M, Masera A, Gugeler N, Decker HJ.
    Cancer Res; 2000 Apr 01; 60(7):1942-8. PubMed ID: 10766184
    [Abstract] [Full Text] [Related]

  • 11. Cloning of the rat homologue of the von Hippel-Lindau tumor suppressor gene and its non-somatic mutation in rat renal cell carcinomas.
    Kikuchi Y, Kobayashi E, Nishizawa M, Hamazaki S, Okada S, Hino O.
    Jpn J Cancer Res; 1995 Oct 01; 86(10):905-9. PubMed ID: 7493907
    [Abstract] [Full Text] [Related]

  • 12. VHL gene alterations in renal cell carcinoma patients: novel hotspot or founder mutations and linkage disequilibrium.
    Ma X, Yang K, Lindblad P, Egevad L, Hemminki K.
    Oncogene; 2001 Aug 30; 20(38):5393-400. PubMed ID: 11536052
    [Abstract] [Full Text] [Related]

  • 13. A novel "Nihon" rat model of a Mendelian dominantly inherited renal cell carcinoma.
    Okimoto K, Kouchi M, Kikawa E, Toyosawa K, Koujitani T, Tanaka K, Matsuoka N, Sakurai J, Hino O.
    Jpn J Cancer Res; 2000 Nov 30; 91(11):1096-9. PubMed ID: 11092972
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
    Zbar B.
    Cancer Surv; 1995 Nov 30; 25():219-32. PubMed ID: 8718521
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model.
    Tsuchiya H, Orimoto K, Kobayashi K, Hino O.
    Cancer Res; 1996 Feb 01; 56(3):429-33. PubMed ID: 8564946
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Analysis of the TSC1 and TSC2 genes in sporadic renal cell carcinomas.
    Parry L, Maynard JH, Patel A, Clifford SC, Morrissey C, Maher ER, Cheadle JP, Sampson JR.
    Br J Cancer; 2001 Oct 19; 85(8):1226-30. PubMed ID: 11710839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.